CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- Open-market buys, last 90 days
- $49,118
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,118. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-23 | Hariri Robert J Director | Grant or award | +34,240 | 34,240 | ||
| 2022-11-23 | Palumbo Joseph M Chief Medical Officer | Grant or award | +39,624 | 39,624 | ||
| 2022-11-23 | Ahlem Clarence N. EVP Neuroscience Product Dev. | Grant or award | +39,624 | 39,624 | ||
| 2022-11-23 | BERMAN RICHARD J Director | Grant or award | +43,578 | 45,178 | ||
| 2022-11-23 | PEIZER TERREN S Director | Grant or award · STOCK OPTION (RIGHT TO BUY) | +65,000 | 65,000 | ||
| 2022-11-23 | KIM JOANNE WENDY Chief Financial Officer | Grant or award | +39,624 | 41,624 | ||
| 2022-11-23 | DO CUONG V CEO & President | Grant or award | +79,248 | 234,848 | ||
| 2022-11-23 | MARKHAM PENELOPE EVP Liver Cirrhosis R&D | Grant or award | +39,624 | 50,317 | ||
| 2022-08-15 | PEIZER TERREN S Director | Grant or award | +3,636,364 | $1.65 | $6.0M | 23,166,210 |
| 2022-08-15 | PEIZER TERREN S Director | Grant or award · Warrants (right to buy) | +7,272,728 | 7,272,728 | ||
| 2022-06-21 | DO CUONG V President & CEO | Grant or award · Stock Option (right to buy) | +124,520 | 124,520 | ||
| 2022-06-21 | DO CUONG V President & CEO | Grant or award · Restricted Stock Unit | +124,520 | 124,520 | ||
| 2022-04-05 | Lang James Paul Director | Grant or award · Stock Option (right to buy) | +127,900 | 127,900 | ||
| 2022-04-05 | ROGICH SIGMUND Director | Grant or award · Stock Option (right to buy) | +123,400 | 123,400 | ||
| 2022-04-05 | Sherman Michael Edward Director | Grant or award · Stock Option (Right to buy) | +130,150 | 130,150 | ||
| 2022-04-05 | GORLIN STEVE Director | Grant or award · Stock Option (right to buy) | +122,250 | 122,250 | ||
| 2022-04-05 | BERMAN RICHARD J Director | Grant or award · Stock Option (right to buy) | +129,050 | 129,050 | ||
| 2022-04-05 | Hariri Robert J Director | Grant or award · Stock Option (right to buy) | +122,250 | 122,250 | ||
| 2022-02-02 | Adams Jonathan M EVP Liver Cirrhosis Programs | Gift | −1,000 | 48,630 | ||
| 2022-02-01 | Palumbo Joseph M Chief Medical Officer | Grant or award · Stock Option (right to buy) | +124,167 | 124,167 |
Page 5 of 10 · 193 trades